Hepatitis A Immunity Test

A blood test for hepatitis A (total anti-HAV) antibodies plus liver function markers (ALT, AST) — confirming whether a patient has protective immunity to hepatitis A virus, and simultaneously assessing current hepatic status. Available at 395 Kč without a prescription, collected at any of 136 Czech collection points. Hepatitis A is endemic in many travel destinations across Asia, Africa, and Latin America. A positive result means existing immunity and no vaccine needed; a negative result indicates susceptibility. Relevant for travellers, healthcare and food service workers, and anyone wanting to confirm vaccine effectiveness. Results in 4 business days. Rated 4.89/5 from 73 reviews.

The Hepatitis A immunity test at Unilabs Online measures anti-HAV total antibodies — the immunoglobulins that confer protection against hepatitis A virus (HAV) infection — combined with liver function markers (ALT and AST) to assess whether any active hepatic inflammation is present. This three-parameter panel is available at 395 Kč without a prescription, collected at any of 136 Czech collection points. Hepatitis A is a notifiable disease spread by the faecal-oral route — primarily through contaminated water, uncooked shellfish, fresh produce, and close contact with infected individuals. It is endemic in many travel destinations across Asia, Africa, Central and South America, and parts of Eastern Europe. The Czech vaccination schedule recommends HAV vaccination for travellers to endemic regions, food handlers, healthcare workers, and patients with chronic liver disease. However, a significant proportion of Czech adults aged 40+ have natural immunity from childhood exposure (when HAV infection was more common) without having been formally vaccinated — making the immunity test a practical step before paying for potentially unnecessary vaccination. The three scenarios where this test most clearly adds value are: (1) pre-travel preparation for endemic destinations (Southeast Asia, India, Egypt, Turkey, Morocco, South America, Central America) — a positive anti-HAV result confirms existing immunity and eliminates the need and cost of a pre-travel vaccine; (2) occupational health compliance for food handlers, healthcare workers, and water treatment employees who need documented immunity confirmation; and (3) confirmation of vaccine effectiveness in immunocompromised patients (chemotherapy, biologics, organ transplant) where seroconversion after vaccination cannot be assumed. A positive anti-HAV total antibody result indicates protective immunity — no vaccination is needed. A negative result means the patient is susceptible to infection and should consider vaccination before travel to endemic areas or in high-risk occupational settings. The ALT and AST markers in the panel simultaneously screen for active hepatic inflammation, providing a complete hepatitis A picture in a single draw. Results are delivered to the patient's secure online account within 4 business days. No fasting or special preparation required.